FFCP PHASE2:Hg19::chr19:1249869..1249894,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@MIDN |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_MIDN_5end |
| Coexpression cluster: | C2_Eosinophils_Neutrophils_CD14_Whole_Basophils_Peripheral_Mast |
| Association with transcript: | 0bp_to_BC060848, BC094778_5end |
| EntrezGene: | MIDN |
| HGNC: | 16298 |
| UniProt: | Q504T8 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@MIDN |
|---|
0
200
400
600
800
1000
1200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| classical monocyte | 3.38e-20 | 42 |
| CD14-positive, CD16-negative classical monocyte | 3.38e-20 | 42 |
| myeloid leukocyte | 4.11e-17 | 72 |
| defensive cell | 7.94e-17 | 48 |
| phagocyte | 7.94e-17 | 48 |
| leukocyte | 1.93e-16 | 136 |
| granulocyte monocyte progenitor cell | 4.33e-13 | 67 |
| monopoietic cell | 4.71e-12 | 59 |
| monocyte | 4.71e-12 | 59 |
| monoblast | 4.71e-12 | 59 |
Showing 1 to 10 of 24 entries
| Ontology term | p-value | n |
|---|---|---|
| hematopoietic system | 2.73e-18 | 98 |
| blood island | 2.73e-18 | 98 |
| hemolymphoid system | 1.26e-15 | 108 |
| bone marrow | 1.04e-12 | 76 |
| immune system | 7.69e-12 | 93 |
| bone element | 8.64e-11 | 82 |
| skeletal element | 1.27e-10 | 90 |
| skeletal system | 6.87e-10 | 100 |
Showing 1 to 8 of 8 entries
